Tenon Medical, Inc. Announces Timing of Second Quarter 2025 Financial Results
Tenon Medical (NASDAQ:TNON), a company focused on Sacroiliac Joint (SIJ) disorders treatment, will release its Q2 2025 financial results after market close on Wednesday, August 13, 2025.
The company will host a conference call at 4:30 p.m. Eastern Time on the same day, featuring a Q&A session with covering analysts. The call will be accessible via telephone and webcast, with replay available through August 27, 2025 on Tenon's Investor Relations website.
Tenon Medical (NASDAQ:TNON), azienda specializzata nel trattamento dei disturbi dell'articolazione sacroiliaca (SIJ), pubblicher脿 i suoi risultati finanziari del secondo trimestre 2025 dopo la chiusura del mercato di mercoled矛 13 agosto 2025.
La societ脿 terr脿 una conference call alle 16:30 ora della costa orientale dello stesso giorno, con una sessione di domande e risposte con gli analisti. La chiamata sar脿 accessibile via telefono e webcast, con la possibilit脿 di riascolto disponibile fino al 27 agosto 2025 sul sito web delle Relazioni con gli Investitori di Tenon.
Tenon Medical (NASDAQ:TNON), una empresa enfocada en el tratamiento de trastornos de la articulaci贸n sacroil铆aca (SIJ), publicar谩 sus resultados financieros del segundo trimestre de 2025 despu茅s del cierre del mercado el mi茅rcoles 13 de agosto de 2025.
La compa帽铆a realizar谩 una llamada conferencia a las 4:30 p.m. hora del Este ese mismo d铆a, con una sesi贸n de preguntas y respuestas con los analistas. La llamada ser谩 accesible por tel茅fono y webcast, con repetici贸n disponible hasta el 27 de agosto de 2025 en el sitio web de Relaciones con Inversionistas de Tenon.
韰岆吋 氅旊敂旎� (NASDAQ:TNON)鞚� 觳滌灔甏�鞝�(SIJ) 歆堩櫂 旃橂鞐� 欤茧牓頃橂姅 須岇偓搿�, 2025雲� 2攵勱赴 鞛 瓴瓣臣毳� 2025雲� 8鞗� 13鞚� 靾橃殧鞚� 鞛� 毵堦皭 頉� 氚滍憸頃� 鞓堨爼鞛呺媹雼�.
須岇偓電� 臧欖潃 雮� 霃欕秬 響滌鞁� 鞓ろ泟 4鞁� 30攵�鞐� 旎嵓霟办姢 旖滌潉 歆勴枆頃橂┌, 鞎犽剱毽姢韸胳檧鞚� 歆堨潣鞚戨嫷 靹胳厴鞚� 韽暔霅╇媹雼�. 鞚� 旖滌潃 鞝勴檾 氚� 鞗轨簮鞀ろ姼搿� 彀胳棳頃� 靾� 鞛堨溂氅�, 2025雲� 8鞗� 27鞚缄箤歆� 韰岆吋 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼鞐愳劀 雼れ嫓 霌ｊ赴臧� 臧�電ロ暕雼堧嫟.
Tenon Medical (NASDAQ:TNON), une soci茅t茅 sp茅cialis茅e dans le traitement des troubles de l'articulation sacro-iliaque (SIJ), publiera ses r茅sultats financiers du deuxi猫me trimestre 2025 apr猫s la cl么ture du march茅 le mercredi 13 ao没t 2025.
La soci茅t茅 organisera une conf茅rence t茅l茅phonique 脿 16h30, heure de l'Est le m锚me jour, comprenant une session de questions-r茅ponses avec les analystes. L'appel sera accessible par t茅l茅phone et webcast, avec une rediffusion disponible jusqu'au 27 ao没t 2025 sur le site des relations investisseurs de Tenon.
Tenon Medical (NASDAQ:TNON), ein Unternehmen, das sich auf die Behandlung von Sakroiliakalgelenksst枚rungen (SIJ) spezialisiert hat, wird seine Finanzergebnisse f眉r das zweite Quartal 2025 nach B枚rsenschluss am Mittwoch, den 13. August 2025 惫别谤枚蹿蹿别苍迟濒颈肠丑别苍.
Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time eine Telefonkonferenz mit einer Fragerunde f眉r Analysten abhalten. Der Anruf ist telefonisch und per Webcast zug盲nglich, mit einer Wiedergabeoption bis zum 27. August 2025 auf der Investor-Relations-Website von Tenon.
- None.
- None.
LOS GATOS, CA / / August 5, 2025 / (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the second quarter 2025 ended June 30, 2025 after market close on Wednesday, August 13, 2025. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.
Date: | Wednesday, August 13, 2025 |
Time: | 4:30 p.m. Eastern time |
Dial-in: | 1-877-407-0792 |
International Dial-in: | 1-201-689-8263 |
Webcast: |
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
An audio playback of the call will be available through August 27, 2025, on Tenon's Investor Relations website at or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International). The access code will be 13754961.
About Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran鈩� Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022, Tenon is focused on three commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants and 3) SI Joint fusion adjunct to a spine fusion construct. For more information, please visit .
The Tenon Medical logo shown above, and Catamaran庐, PiSIF庐, CAT PiSIF庐, ETAD庐, Posterior Inferior Sacroiliac Fusion庐, CAT SIJ Fusion System庐, Catamaran SIJ Fusion System庐, Catamaran Inferior Posterior Fusion System庐, Catamaran Transfixation Fusion System庐, and Catamaran Transfixation Fusion Device庐 are registered trademarks of Tenon Medical, Inc. MAINSAILTM is also a trademark of Tenon Medical, Inc.
Investor Contact
Shannon Devine
MZ North America
203-741-8811
[email protected]
SOURCE: Tenon Medical, Inc.
View the original on ACCESS Newswire
FAQ
When will Tenon Medical (TNON) release Q2 2025 earnings?
How can investors join Tenon Medical's Q2 2025 earnings call?
How long will Tenon Medical's Q2 2025 earnings call replay be available?
What does Tenon Medical (TNON) specialize in?
